Sector: Healthcare | Industry: Pharmaceuticals |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 6555 State Highway 161 IRVING TX 75039 |
Tel: | N/A |
Website: | https://www.mckesson.com |
IR: | See website |
Key People | ||
Brian Scott Tyler Chief Executive Officer, Director | Britt J. Vitalone Chief Financial Officer, Executive Vice President | Leann B. Smith Chief Human Resource Officer, Executive Vice President |
Francisco Fraga Executive Vice President, Chief Technology Officer, Chief Information Officer | Michele Lau Executive Vice President, Chief Legal Officer | Tom L. Rodgers Executive Vice President, Chief Strategy and Business Development Officer |
Business Overview |
McKesson Corporation is a provider of diversified healthcare services. The Company is engaged in advancing health outcomes for patients everywhere. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over the counter (OTC) pharmaceutical drugs and other healthcare-related products in the United States. Its Prescription Technology Solutions segment helps solve medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Its Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home healthcare agencies. Its International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. |
Financial Overview |
For the nine months ended 31 December 2023, McKesson Corp revenues increased 12% to $232.6B. Net income before extraordinary items decreased 20% to $2.21B. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was offset by U.S. Pharmaceutical segment income decrease of 63% to $900M, Medical-Surgical Solutions segment income decrease of 42% to $512M. |
Employees: | 45,000 as of Mar 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $72,085M as of Dec 31, 2023 |
Annual revenue (TTM): | $301,506M as of Dec 31, 2023 |
EBITDA (TTM): | $4,358M as of Dec 31, 2023 |
Net annual income (TTM): | $2,998M as of Dec 31, 2023 |
Free cash flow (TTM): | $2,584M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | $3,909M as of Dec 31, 2023 |
Shares outstanding: | 131,408,286 as of Dec 31, 2023 |
Index Membership: | S&P 500 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |